UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 0.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,541,393 shares of the company's stock after acquiring an additional 20,180 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.56% of GE HealthCare Technologies worth $162,675,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of GEHC. Western Wealth Management LLC increased its position in shares of GE HealthCare Technologies by 2.4% during the fourth quarter. Western Wealth Management LLC now owns 5,240 shares of the company's stock worth $430,000 after purchasing an additional 125 shares in the last quarter. Parkside Financial Bank & Trust boosted its position in shares of GE HealthCare Technologies by 3.9% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company's stock worth $293,000 after purchasing an additional 134 shares in the last quarter. Quadrant Capital Group LLC grew its stake in GE HealthCare Technologies by 1.1% during the 4th quarter. Quadrant Capital Group LLC now owns 12,557 shares of the company's stock worth $1,030,000 after buying an additional 140 shares during the last quarter. Mount Vernon Associates Inc. MD grew its stake in GE HealthCare Technologies by 0.8% during the 1st quarter. Mount Vernon Associates Inc. MD now owns 18,165 shares of the company's stock worth $1,293,000 after buying an additional 144 shares during the last quarter. Finally, Norinchukin Bank The increased its position in GE HealthCare Technologies by 0.4% during the 3rd quarter. Norinchukin Bank The now owns 38,913 shares of the company's stock valued at $2,922,000 after buying an additional 149 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on GEHC shares. Evercore reissued an "outperform" rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Piper Sandler restated a "buy" rating on shares of GE HealthCare Technologies in a report on Wednesday, July 29th. Zacks Research raised shares of GE HealthCare Technologies from a "strong sell" rating to a "hold" rating in a research report on Tuesday, August 11th. UBS Group lifted their target price on shares of GE HealthCare Technologies from $67.00 to $73.00 and gave the stock a "neutral" rating in a research note on Friday, July 31st. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of GE HealthCare Technologies in a research report on Wednesday, August 12th. Ten research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $77.73.
Read Our Latest Analysis on GE HealthCare Technologies
GE HealthCare Technologies Stock Down 1.1%
GE HealthCare Technologies stock opened at $70.42 on Wednesday. The business's 50-day simple moving average is $68.02 and its two-hundred day simple moving average is $69.14. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26. The company has a market cap of $31.81 billion, a PE ratio of 16.15, a PEG ratio of 1.88 and a beta of 0.70. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The firm had revenue of $5.29 billion during the quarter, compared to analysts' expectations of $5.26 billion. During the same period last year, the business posted $1.06 earnings per share. The company's revenue for the quarter was up 5.8% compared to the same quarter last year. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.93 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Friday, July 24th were given a dividend of $0.035 per share. The ex-dividend date of this dividend was Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.21%.
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
